These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4119765)

  • 1. Treatment of dermatitis herpetiformis.
    Alexander JO
    Lancet; 1973 Feb; 1(7800):439-40. PubMed ID: 4119765
    [No Abstract]   [Full Text] [Related]  

  • 2. Discontinuing dapsone treatment and reintroducing dietary gluten in patients with dermatitis herpetiformis in remission: comment on "remission in dermatitis herpetiformis".
    Mostow EN
    Arch Dermatol; 2011 Mar; 147(3):305-6. PubMed ID: 21422338
    [No Abstract]   [Full Text] [Related]  

  • 3. Acetylator phenotype, minimal maintenance dose and haemolytic effect of dapsone in dermatitis herpetiformis.
    Förström L; Mattila MJ; Mustakallio KK
    Ann Clin Res; 1974 Oct; 6(5):308-10. PubMed ID: 4447343
    [No Abstract]   [Full Text] [Related]  

  • 4. Dermatitis herpetiformis: consequences of elemental diet.
    Zeedijk N; van der Meer JB; Poen H; van der Putte SC
    Acta Derm Venereol; 1986; 66(4):316-20. PubMed ID: 2430402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
    Révész K; Schneider I
    Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and management of dermatitis herpetiformis.
    Leonard JN; Fry L
    Clin Dermatol; 1991; 9(3):403-8. PubMed ID: 1806228
    [No Abstract]   [Full Text] [Related]  

  • 7. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone in dermatitis herpetiformis and other immunological diseases.
    Dahl MG
    Lancet; 1977 Feb; 1(8008):429. PubMed ID: 65542
    [No Abstract]   [Full Text] [Related]  

  • 9. Fine points in the management of dermatitis herpetiformis.
    Fry L
    Semin Dermatol; 1988 Sep; 7(3):206-11. PubMed ID: 3153446
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful pregnancy in a patient with dermatitis herpetiformis treated with low-dose dapsone.
    Tuffanelli DL
    Arch Dermatol; 1982 Nov; 118(11):876. PubMed ID: 7138039
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism and haemolytic effect of dapsone and its metabolites in man.
    Halmekoski J; Mattila MJ; Mustakallio KK
    Med Biol; 1978 Aug; 56(4):216-21. PubMed ID: 703406
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical Dapsone 5% Gel as an Effective Therapy in Dermatitis Herpetiformis.
    Burbidge T; Haber RM
    J Cutan Med Surg; 2016 Nov; 20(6):600-601. PubMed ID: 27207357
    [No Abstract]   [Full Text] [Related]  

  • 13. Dapsone for treatment of pruritic dermatitis (dermatitis herpetiformis and subcorneal pustular dermatosis) in dogs.
    Halliwell RE; Schwartzman RM; Ihrke PJ; Goldschmidt MH; Wood MG
    J Am Vet Med Assoc; 1977 Apr; 170(7):697-703. PubMed ID: 858685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term treatment of Duhring's dermatitis herpetiformis].
    Marks J; Shuster S
    Hautarzt; 1977 Sep; 28(9):500. PubMed ID: 410754
    [No Abstract]   [Full Text] [Related]  

  • 15. Agranulocytosis during dapsone administration.
    Ten Broeke JE; Cunningham LD
    Dermatologica; 1973; 146(1):21-4. PubMed ID: 4694139
    [No Abstract]   [Full Text] [Related]  

  • 16. [Management of dermatitis herpetiformis].
    Schuppli R
    Dtsch Med Wochenschr; 1968 Nov; 93(48):2343. PubMed ID: 4301398
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of Duhring's dermatitis herpetiformis in childhood with diaminodiphenylsulfone (DDS)].
    Schwenke W; Ladstätter L; Stolp A
    Padiatr Grenzgeb; 1969; 8(2):109-21. PubMed ID: 5380550
    [No Abstract]   [Full Text] [Related]  

  • 18. Dapsone and human polymorphonuclear leucocyte chemotaxis in dermatitis herpetiformis.
    Millar BW; Macdonald KJ; Macleod TM; Raffle EJ
    Acta Derm Venereol; 1984; 64(5):433-6. PubMed ID: 6208726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lessons from a case treated with a drug thought a teratogen].
    Boda D
    Orv Hetil; 2004 Oct; 145(40):2067-8. PubMed ID: 15559535
    [No Abstract]   [Full Text] [Related]  

  • 20. Dapsone and severe hypoalbuminaemia in dermatitis herpetiformis.
    Cowan RE; Wright JT
    Br J Dermatol; 1981 Feb; 104(2):201-4. PubMed ID: 7213552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.